Filing Details
- Accession Number:
- 0001209191-19-005422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-25 18:24:39
- Reporting Period:
- 2019-01-23
- Accepted Time:
- 2019-01-25 18:24:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1478485 | M Peter Hecht | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2019-01-23 | 30,000 | $4.89 | 4,726,917 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2019-01-23 | 30,000 | $12.66 | 4,696,917 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2019-01-24 | 30,000 | $4.89 | 4,726,917 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2019-01-24 | 30,000 | $12.70 | 4,696,917 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2019-01-25 | 29,551 | $4.89 | 4,726,468 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2019-01-25 | 29,551 | $12.23 | 4,696,917 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2019-01-25 | 20,449 | $4.89 | 4,717,366 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-01-23 | 30,000 | $0.00 | 30,000 | $4.89 |
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-01-24 | 30,000 | $0.00 | 30,000 | $4.89 |
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-01-25 | 29,551 | $0.00 | 29,551 | $4.89 |
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-01-25 | 20,449 | $0.00 | 20,449 | $4.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,000 | 2019-02-11 | No | 4 | M | Direct | |
50,000 | 2019-02-11 | No | 4 | M | Direct | |
20,449 | 2019-02-11 | No | 4 | M | Direct | |
0 | 2019-02-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 4,850 | Indirect | The 2000 Trust for Alexis Mae Hecht |
Class A Common Stock | 4,850 | Indirect | The 2000 Trust for Malcolm Paul Hecht |
Class A Common Stock | 4,850 | Indirect | The 2000 Trust for Zoe Niovi Hecht |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.40 to $12.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $13.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.
- The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2013.